| IPI00555059 - Prdx6, PEROXIREDOXIN-6. | |
|---|---|
| Uniprot Accession: Q53ZU7 | |
| Uniprot ID: Q53ZU7_MOUSE | |
| Mapping: Chr 1, 163076789 - 163087843 | |
| Entrez Gene: 11758 | |
| Entrez MapView: |
|
| MGI: MGI:894320 | |
| +All IPI Database Cross References | |
| IPI records in this ortholog cluster (Cluster: MGI_ORTHOLOGY_11409) |
|---|
| Rat: Prdx6, PEROXIREDOXIN-6. |
| Mouse: Prdx6, PRODUCT:PEROXIREDOXIN 5, FULL INSERT SEQUENCE. |
| Mouse: Prdx6, PEROXIREDOXIN-6. |
| Mouse: Prdx6, 22 KDA PROTEIN. |
| Mouse: Prdx6, PEROXIREDOXIN 6. |
| Rat: Prdx6, 20 KDA PROTEIN. |
| Human: PRDX6, PEROXIREDOXIN-6. |
| GO Term | Aspect | Human | Mouse | Rat |
|---|---|---|---|---|
| lysosome | C | IEA | IEA | IEA |
| cytoplasm | C | IEA | IEA | |
| cytoplasmic vesicle | C | IEA | ||
| cytosol | C | NAS | IDA | ISS ISS |
| glutathione peroxidase activity | F | IDA | ||
| peroxiredoxin activity | F | IEA | IEA | IEA |
| hydrolase activity | F | IEA | IEA | IEA |
| thioredoxin peroxidase activity | F | ISS | ||
| phospholipase A2 activity | F | IDA | ISS IEA | |
| peroxidase activity | F | IMP | ISS | |
| antioxidant activity | F | IEA IEA | ||
| catalytic activity | F | IEA | ||
| oxidoreductase activity | F | IEA | IEA IEA | IEA |
| phospholipid catabolic process | P | IDA | ISS IEA | |
| response to reactive oxygen species | P | IMP | ISS | |
| response to oxidative stress | P | IDA | ISS IEA | |
| lipid catabolic process | P | IEA | IEA | IEA |
| hydrogen peroxide catabolic process | P | IDA |
| GO Graph Color Key: | Rat | Mouse | Human | Rat & Mouse | Mouse & Human | Rat & Human | Rat, Mouse & Human |
SVG image
| GO Graph Color Key: | Rat | Mouse | Human | Rat & Mouse | Mouse & Human | Rat & Human | Rat, Mouse & Human |
SVG image
| GO Graph Color Key: | Rat | Mouse | Human | Rat & Mouse | Mouse & Human | Rat & Human | Rat, Mouse & Human |
SVG image
| MP Term | Aspect | Human | Mouse | Rat |
|---|---|---|---|---|
| cellular phenotype | MP | Un | ||
| homeostasis/metabolism phenotype | MP | Un | ||
| renal/urinary system phenotype | MP | Un | ||
| respiratory system phenotype | MP | Un | ||
| cardiovascular system phenotype | MP | Un | ||
| normal phenotype | MP | Un |
| DO Term | Aspect | Human | Mouse | Rat |
|---|---|---|---|---|
| Arteriosclerosis | D | ISS | ||
| Reperfusion Injury | D | ISS |
| PW Term | Aspect | Human | Mouse | Rat |
|---|---|---|---|---|
| phenylalanine metabolic pathway | W | IEA | ||
| stilbene, coumarine and lignin biosynthetic pathway | W | IEA | ||
| eicosanoids metabolic pathway | W | IEA | ||
| alkaloid biosynthetic pathway II | W | IEA | ||
| butanoate metabolic pathway | W | IEA | ||
| methane metabolic pathway | W | IEA |
| KEGG Pathway | Human | Mouse | Rat |
|---|---|---|---|
| Stilbene, coumarine and lignin biosynthesis (00940) | Present in KEGG pathway | Present in KEGG pathway | Present in KEGG pathway |
| 2,4-Dichlorobenzoate degradation (00623) | Present in KEGG pathway | Present in KEGG pathway | Not present in KEGG pathway |
| Methane metabolism (00680) | Present in KEGG pathway | Present in KEGG pathway | Present in KEGG pathway |
| Alkaloid biosynthesis II (00960) | Present in KEGG pathway | Present in KEGG pathway | Present in KEGG pathway |
| Phenylalanine metabolism (00360) | Present in KEGG pathway | Present in KEGG pathway | Present in KEGG pathway |
| Butanoate metabolism (00650) | Present in KEGG pathway | Present in KEGG pathway | Present in KEGG pathway |